Wuhan firm鈥檚 DPT vaccines 鈥榗leared鈥
Print Edition
A BATCH of DPT vaccines produced in Wuhan found to be substandard was an isolated case and the company has recalled all unused substandard vaccines, China鈥檚 drug regulator said on Tuesday.
Spot checks in 2017 found that a batch of 400,520 doses of DPT vaccines produced by Wuhan Institute of Biological Products Co failed to meet standards. The main cause of the defects was found to be a short-term failure in the packaging equipment, said a spokesperson with the State Drug Administration.
The spokesperson said all unused DPT vaccines found to be substandard have been recalled by the company and destroyed.
Tests on other batches of DTP vaccine produced by the firm showed they all met standards, the spokesperson added.
DPT refers to a combination of vaccines against three infectious diseases: diphtheria, pertussis, and tetanus.
Wuhan Institute of Biological Products Co was fined and its illegal gains confiscated.
The local drug regulator demanded the company rectify improper practices and ensure the normal operation of its equipment. An inspection conducted in March by the national drug regulator found that the company had completed the rectification process, according to the spokesperson.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
